Phase I trial of intravenous 17-allylaminogeldanamycin (A) and oral sorafenib (B) in pretreated advanced malignancy: Plasma Hsp90α induction correlates with clinical benefit
Year: 2007
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: U. N. Vaishampayan, E. A. Sausville, M. N. Horiba, M. Quinn, L. K. Heilbrun, A. Burger, P. Ivy, J. Li, P. Lorusso
Language: English
Topic: Heat shock proteins research
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2264447605